Combinations of a GLP1R agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders

The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that compr...

Full description

Saved in:
Bibliographic Details
Main Authors Clark, Bradley Alan, Quada Jr., James C, Yokum, Thomas Scott, Mjalli, Adnan M. M, Andrews, Robert Carl, Polisetti, Dharma Rao, Valcarce Lopez, Maria Carmen, Davis, Stephen Thomas
Format Patent
LanguageEnglish
Published 11.10.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that comprise a GLP1R agonist and metformin.
Bibliography:Application Number: AU20140207748